14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 002644.SZ
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Lanzhou Foci Pharmaceutical Co Ltd stock downgraded after the last trading session.
(Updated on Apr 25, 2024)

Sell candidate since Apr 25, 2024 PDF

The Lanzhou Foci Pharmaceutical Co Ltd stock price gained 1.23% on the last trading day (Thursday, 25th Apr 2024), rising from ¥7.34 to ¥7.43. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 4.75% from a day low at ¥7.16 to a day high of ¥7.50. The price has been going up and down for this period, and there has been a -4.74% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 793 thousand more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately ¥27.32 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.64% during the next 3 months and, with a 90% probability hold a price between ¥7.01 and ¥9.47 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

002644.SZ Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 8.78%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lanzhou Foci Pharmaceutical Co Ltd stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at ¥7.83. On a fall, the stock will find some support from the short-term average at ¥7.26. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Lanzhou Foci Pharmaceutical Co Ltd stock

Lanzhou Foci Pharmaceutical Co Ltd finds support from accumulated volume at ¥7.28 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved ¥0.340 between high and low, or 4.75%. For the last week, the stock has had daily average volatility of 4.97%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (002644.SZ) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Lanzhou Foci Pharmaceutical Co Ltd to open at ¥7.36, and during the day (based on 14 day Average True Range), to move between ¥7.02 and ¥7.84, which gives a possible trading interval of +/-¥0.409 (+/-5.51%) up or down from last closing price. If Lanzhou Foci Pharmaceutical Co Ltd takes out the full calculated possible swing range there will be an estimated 11.01% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at ¥7.28 (2.02%) than the resistance at ¥8.36 (12.52%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Lanzhou Foci Pharmaceutical Co Ltd will release earnings BMO on Tuesday, April 30, 2024. We will update the financials statements for Lanzhou Foci Pharmaceutical Co Ltd, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 5.61% in the first trading day after earnings release.

Is Lanzhou Foci Pharmaceutical Co Ltd stock A Buy?

Lanzhou Foci Pharmaceutical Co Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.401 Sell Candidate Downgraded

Predicted Opening Price for Lanzhou Foci Pharmaceutical Co Ltd of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
¥7.36 ( 0.90%) ¥7.43

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 002644.SZ

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 7.70 3.68 %
R2 7.57 1.93 %
R1 7.49 0.85 %
Current price: 7.43
Support S1 7.23 -2.65 %
S2 7.15 -3.73 %
S3 7.02 -5.47 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 8.72 17.36 %
R2 8.45 13.73 %
R1 8.36 12.52 %
Current price 7.43
Support S1 7.28 -2.02%
S2 7.19 -3.23%
S3 6.83 -8.08%

002644 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 15, 2023 Jun 15, 2023 Jun 15, 2023 ¥0.0500 0.430%
2 May 27, 2022 May 27, 2022 May 27, 2022 ¥0.0100 0.110%
3 Jul 09, 2021 Jul 09, 2021 Jul 09, 2021 ¥0.120 1.35%
4 Jun 12, 2020 Jun 12, 2020 Jun 12, 2020 ¥0.0600 0.743%
5 Jun 05, 2019 Jun 05, 2019 Jun 05, 2019 ¥0.0130 0.179%

FAQ

What is the symbol for Lanzhou Foci Pharmaceutical Co Ltd Stock and on which exchange is it traded?
The symbol for Lanzhou Foci Pharmaceutical Co Ltd is 002644.SZ and it is traded on the SZCE (Shenzhen Stock Exchange).

Should I buy or sell Lanzhou Foci Pharmaceutical Co Ltd Stock?
Lanzhou Foci Pharmaceutical Co Ltd holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Lanzhou Foci Pharmaceutical Co Ltd Stock?
Lanzhou Foci Pharmaceutical Co Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lanzhou Foci Pharmaceutical Co Ltd Stock.

What's the current price of Lanzhou Foci Pharmaceutical Co Ltd Stock?
As of the end of day on the Apr 25, 2024, the price of an Lanzhou Foci Pharmaceutical Co Ltd (002644.SZ) share was ¥7.43.

What is the 52-week high and low for Lanzhou Foci Pharmaceutical Co Ltd Stock?
The 52-week high for Lanzhou Foci Pharmaceutical Co Ltd Stock is ¥14.94 and the 52-week low is ¥5.84.

What is the market capitalization of Lanzhou Foci Pharmaceutical Co Ltd Stock?
As of the Apr 25, 2024, the market capitalization of Lanzhou Foci Pharmaceutical Co Ltd is 3.794B.

When is the next earnings date for Lanzhou Foci Pharmaceutical Co Ltd?
The upcoming earnings date for Lanzhou Foci Pharmaceutical Co Ltd is Apr 30, 2024.
Click to get the best stock tips daily for free!

About Lanzhou Foci Pharmaceutical Co Ltd

LanZhou Foci Pharmaceutical Co.,Ltd., a pharmaceutical company, manufactures and sells traditional Chinese medicines in China. It offers its products in various dosage forms, including pills, tablets, capsules, and granules under the Min Shan and Foci brands. The company also engages in researching activities for the development of new herbal drugs. It also exports its products to approximately 27 countries, which include the United States, Canad... 002644.SZ Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT